CN
|
EN
Home
Introduction to the 2023 CBIIC
Main Conference
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Agenda
Previous Speakers
News
Expert
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Business Matching Service
Register
Roadshow Application
Onsite Participant Registration
CN
EN
Non-Listed Company Roadshow
Agendas
9:00 - 12:10
非上市公司路演专场
Non-Listed Company Roadshow
Moderator
徐佳熹 , 兴业证券董事总经理,自营分公司副总经理
XU Jiaxi , Managing Director, China Industrial Securities
9:00 - 9:30
主题报告1
Keynote Speech 1
“数据、情报、战略”:如何用大数据解锁新药差异化立项和平衡研发风险
"Data, Intelligence, Strategy": How to Unlock New Drug Differentiation Project Initiation and Balance R&D Risks with Big Data
龚元香 珠海横琴濠麦科技有限公司联合创始人&总经理
Lena GONG , Co Founder and General Manager of Zhuhai Hengqin Haomai Technology Co., Ltd.
9:30 - 9:50
项目1
Project 1
SynNeogen®平台-慢性乙肝和前列腺癌治疗性疫苗的临床开发全新策略
SynNeogen® Platform-A noval Strategy for the Development of Therapeutic Vaccines for Chronic HBV Infection and Prostate Cancer
史跃年 凯米生物医药(成都)有限公司创始人、董事长、首席执行官
SHI Yuenian , Founder, Chairman and CEO, Chimigen Biomedical (Chengdu) Co., Ltd.
9:50 - 10:10
项目2
Project 2
杜氏肌营养不良碱基编辑药物研究开发
Research and Development of DMD Base Editing Drug
何春艳 苏州新芽基因生物技术有限公司首席执行官
Chelsie HE , CEO, Suzhou GenAssist Co., Ltd.
10:10 - 10:30
项目3
Project 3
立足原始创新与临床差异化实践的新药研发策略
Innovative Drug Development Strategy Based on Original Innovation and Clinical Differentiation Practice
周星露 杭州和正医药有限公司首席执行官
ZHOU Xinglu , CEO, HealZen Therapeutics Co., Ltd.
10:30 - 10:50
项目4
Project 4
抗病毒和肝脏类疾病创新药开发
Research and Development of Innovative Drugs for Antiviral and Liver Diseases
张玉华 福建广生中霖生物科技有限公司总经理
George ZHANG , CEO, Fujian Akeylink Bio
10:50 - 11:10
项目5
Project 5
基于脆弱拟杆菌的创新活体药开发
Innovative in Vivo Drug Development Based on Bacteroides Fragilis
王晔 广州知易生物科技有限公司首席执行官
WANG Ye , CEO, Guangzhou Zhiyi Biotechnology Co., Ltd.
11:10 - 11:30
项目6
Project 6
用表型筛选系统开发治疗CNS的FIC药物
Discovery and Development of FIC Drug in CNS by Phenotypic Screening
马伟伟 北京卓凯生物技术有限公司总经理
MA Weiwei , CEO, Beijing Joekai Biotechnology Llc
11:30 - 11:50
项目7
Project 7
聚焦肿瘤与肾病未满足临床需求,做好药为生命更美好
Focused on the Unmet Needs in Oncology and Nephrology, Making Better Medicine for Better Life
黑永疆 无锡智康弘义生物科技有限公司联席首席执行官
HEI Yongjiang , Co-CEO, Biocity Biopharma
11:50 - 12:10
项目8
Project 8
澳宗生物于CNS领域新药研发进展
Auzone Bio's New Drug Discovery and Development Progress in the CNS Field
侯尚伟 苏州澳宗生物科技有限公司首席运营官
HOU Shangwei , Chief Operating Officer, Suzhou Auzone Biotechnology Co., Ltd.